A Two-Step Approach to Reduced Intensity Bone Marrow Transplant for Patients With Hematological Malignancies
Thomas Jefferson University
Thomas Jefferson University
Henan Cancer Hospital
Eli Lilly and Company
BeOne Medicines
Gilead Sciences
H. Lee Moffitt Cancer Center and Research Institute
Incyte Corporation
Masonic Cancer Center, University of Minnesota
University of Maryland, Baltimore
Masonic Cancer Center, University of Minnesota
University of Washington
Hutchmed
Fred Hutchinson Cancer Center
International Extranodal Lymphoma Study Group (IELSG)
AstraZeneca
BeiGene
BeiGene
Innovent Biologics (Suzhou) Co. Ltd.
University of Colorado, Denver
City of Hope Medical Center
City of Hope Medical Center
Mayo Clinic
University of Nebraska
University of Nebraska
University of Nebraska
University of Nebraska
Agenus Inc.
Masonic Cancer Center, University of Minnesota
University of Nebraska
TG Therapeutics, Inc.
Eastern Cooperative Oncology Group
Abramson Cancer Center at Penn Medicine
M.D. Anderson Cancer Center
International Extranodal Lymphoma Study Group (IELSG)
The Lymphoma Academic Research Organisation
Mayo Clinic
Seoul National University Hospital
Universität des Saarlandes
Fred Hutchinson Cancer Center
Masonic Cancer Center, University of Minnesota
National Cancer Institute (NCI)
M.D. Anderson Cancer Center
Masonic Cancer Center, University of Minnesota
Jonsson Comprehensive Cancer Center
National Cancer Institute (NCI)
Roswell Park Cancer Institute
Fred Hutchinson Cancer Center
Fred Hutchinson Cancer Center
University of Arizona
Fred Hutchinson Cancer Center